August 6, 2025

Doctors Report Concerns about Overprescribing and Continuity of Care with Patient Access to GLP-1 Medications through Third-Party Telehealth

While demand for GLP-1s remains high, reports show that medication persistence is surprisingly low. GLP-1 discontinuation can be a concern for payers and patients alike, as clinical trial results indicate that people may regain a considerable amount of weight once they stop the GLP-1. However, does weight health progress have to stop when people discontinue their GLP-1? Is it possible that virtual programs—which have long been in the business of weight health—offer tailored tools and support that could lead to successful weight maintenance?

 

Omada Health

Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 29 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada’s scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.

The foundation of Omada’s success is a strong, vibrant work culture, which helped earn the company the distinction of becoming an officially certified Great Place to Work. An industry leader, Omada was the first virtual provider to join the Institute for Healthcare Improvement’s Leadership Alliance, reflecting the aim to complement primary care providers for the benefit of members, and affirming its guarantee to every partner: Omada works differently.

Contacts:
Rose Ramseth
press@omadahealth.com

Become an Omada Insider
Sign Up